Related Experiment Video
Updated: May 17, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Clostridium difficile infection: new insights into management
Sahil Khanna1, Darrell S Pardi
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Clostridium difficile infection (CDI) is a growing threat, with rising rates and severity. Emerging treatments like fecal microbiota transplantation offer new hope for managing this challenging hospital-acquired infection.
Area of Science:
- Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Clostridium difficile infection (CDI) is a leading cause of hospital-acquired infections in the US.
- CDI incidence, severity, and recurrence rates have increased significantly over the past two decades.
- Increased CDI rates are associated with poorer patient outcomes.
Purpose of the Study:
- To review the evolving epidemiology of Clostridium difficile infection.
- To identify novel risk factors contributing to CDI.
- To discuss emerging and promising treatment strategies for CDI.
Main Methods:
- Literature review focusing on recent studies and clinical data.
- Analysis of epidemiological trends and risk factor identification.
- Evaluation of novel therapeutic interventions for CDI.
Main Results:
- CDI remains a significant healthcare-associated pathogen with increasing challenges.
- New risk factors are being identified, contributing to the complexity of CDI.
- Promising new treatments include fidaxomicin, monoclonal antibodies, and fecal microbiota transplantation.
Conclusions:
- Clostridium difficile infection presents an escalating public health concern.
- Understanding changing epidemiology and risk factors is crucial for effective prevention and treatment.
- Novel therapies demonstrate potential for improved CDI management and outcomes.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management
Urinary Tract Infection IV: Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Endocarditis III: Medical Management
Clinical Significance of Antibiotic Resistance
